-
Tetra Bio-Pharma Gets CA$4.5M From Québec's Government To Develop Medicine For ARDS
Wednesday, February 16, 2022 - 8:28am | 397Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB: TBPMF) (FRA: JAM1) announced the approval of a CA$4.5 million ($3.53 million) participative loan from the ministère de l'Économie et de l'Innovation (MEI) under the BioMed Propulsion Program, managed by Investissement Québec (IQ...
-
Tetra Bio-Pharma & Avicanna Enter Into Strategic Partnership
Monday, February 14, 2022 - 8:29am | 379Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) announced that it has executed a non-binding term sheet with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to assess entering into a strategic partnership comprising of three strategic pillars, including: The registration and...